The impact of COVID-19 on a Southern Chinese cohort with neuromyelitis optica spectrum disorders
Description
CONCLUSIONS: NMOSD patients with younger age, lower baseline ADL or mRS had higher incidence of being diagnosed with COVID-19 during pandemic. Glucocorticoid use may decrease the risk of COVID-19. NMOSD patients with symptomatic cerebral syndrome